These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 29739039)
21. Combination of ULK1 and LC3B improve prognosis assessment of hepatocellular carcinoma. Wu DH; Wang TT; Ruan DY; Li X; Chen ZH; Wen JY; Lin Q; Ma XK; Wu XY; Jia CC Biomed Pharmacother; 2018 Jan; 97():195-202. PubMed ID: 29091866 [TBL] [Abstract][Full Text] [Related]
22. Levels of HBx, VEGF, and CEACAM1 in HBV-related hepatocellular carcinoma and their correlation with cancer prognosis. Mao CS; Yin H; Ning HB; Peng Z; Li K; Ding GQ Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3827-3833. PubMed ID: 28975984 [TBL] [Abstract][Full Text] [Related]
23. Overexpression of squamous cell carcinoma antigen 1 is associated with the onset and progression of human hepatocellular carcinoma. Liu J; Gao Y; Yang B; Jia X; Zhai D; Li S; Zhang Q; Jing L; Wang Y; Du Z; Wang Y Arch Med Res; 2015 Feb; 46(2):133-41. PubMed ID: 25819271 [TBL] [Abstract][Full Text] [Related]
24. [Expression of Nodal in hepatocellular carcinoma and its relationship with angiogenesis and epithelial-mesenchymal transition]. Chen J; Li J; Liu W; Jia W; Xu G; Ma J Zhonghua Wai Ke Za Zhi; 2014 Mar; 52(3):188-92. PubMed ID: 24785457 [TBL] [Abstract][Full Text] [Related]
25. High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma. Liao W; Huang G; Liao Y; Yang J; Chen Q; Xiao S; Jin J; He S; Wang C Oncotarget; 2014 Nov; 5(21):10271-9. PubMed ID: 25431949 [TBL] [Abstract][Full Text] [Related]
26. Increased expression of ZBP-89 and its prognostic significance in hepatocellular carcinoma. Zhang CZ; Cao Y; Yun JP; Chen GG; Lai PB Histopathology; 2012 Jun; 60(7):1114-24. PubMed ID: 22372401 [TBL] [Abstract][Full Text] [Related]
27. Prognostic Significance of 14-3-3ε, Aldo-keto Reductase Family 1 B10 and Metallothionein-1 in Hepatocellular Carcinoma. Wu CY; Jan YJ; Ko BS; Wu YJ; Wu YJ; Liou JY Anticancer Res; 2018 Dec; 38(12):6855-6863. PubMed ID: 30504401 [TBL] [Abstract][Full Text] [Related]
28. Decreased expression of SOX6 confers a poor prognosis in hepatocellular carcinoma. Guo X; Yang M; Gu H; Zhao J; Zou L Cancer Epidemiol; 2013 Oct; 37(5):732-6. PubMed ID: 23731550 [TBL] [Abstract][Full Text] [Related]
29. EIF4EBP1 overexpression is associated with poor survival and disease progression in patients with hepatocellular carcinoma. Cha YL; Li PD; Yuan LJ; Zhang MY; Zhang YJ; Rao HL; Zhang HZ; Zheng XF; Wang HY PLoS One; 2015; 10(2):e0117493. PubMed ID: 25658620 [TBL] [Abstract][Full Text] [Related]
30. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma. Orimo T; Ojima H; Hiraoka N; Saito S; Kosuge T; Kakisaka T; Yokoo H; Nakanishi K; Kamiyama T; Todo S; Hirohashi S; Kondo T Hepatology; 2008 Dec; 48(6):1851-63. PubMed ID: 18937283 [TBL] [Abstract][Full Text] [Related]
31. Mastermind-like Transcriptional Coactivator 1 Overexpression Predicts Poor Prognosis in Human with Hepatocellular Carcinoma. Wang J; Zhang SM; Wu JM; Lu ZC; Yang JR; Wu HS; Chen H; Lin B; Xu RH; Cao TS Ann Clin Lab Sci; 2016 Sep; 46(5):502-7. PubMed ID: 27650617 [TBL] [Abstract][Full Text] [Related]
32. [Clinical significance of RYBP expression in primary hepatocellular carcinoma]. Jing X; Cai W; Huang B; Chen H; Chen D Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 44(4):399-405. PubMed ID: 31113915 [TBL] [Abstract][Full Text] [Related]
33. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients. Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282 [TBL] [Abstract][Full Text] [Related]
34. Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas. Yu B; Yang X; Xu Y; Yao G; Shu H; Lin B; Hood L; Wang H; Yang S; Gu J; Fan J; Qin W J Hepatol; 2009 May; 50(5):948-57. PubMed ID: 19303159 [TBL] [Abstract][Full Text] [Related]
35. Low expression of NEK2 is associated with hepatocellular carcinoma progression and poor prognosis. Fu L; Liu S; Wang H; Ma Y; Li L; He X; Mou X; Tong X; Hu Z; Ru G Cancer Biomark; 2017 Jul; 20(1):101-106. PubMed ID: 28759960 [TBL] [Abstract][Full Text] [Related]
36. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma. Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007 [TBL] [Abstract][Full Text] [Related]
37. Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein. Ren YJ; Huang T; Yu HL; Zhang L; He QJ; Xiong ZF; Peng H J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):846-851. PubMed ID: 27924522 [TBL] [Abstract][Full Text] [Related]
38. CC chemokine receptor 6 expression predicts poor prognosis in hepatocellular carcinoma. Liu F; Lv H; Jia X; Liu G; Li T; Xu Z; Li J J Surg Oncol; 2014 Aug; 110(2):151-5. PubMed ID: 24634224 [TBL] [Abstract][Full Text] [Related]
39. Increased expression of cathepsin L: a novel independent prognostic marker of worse outcome in hepatocellular carcinoma patients. Ruan J; Zheng H; Fu W; Zhao P; Su N; Luo R PLoS One; 2014; 9(11):e112136. PubMed ID: 25384089 [TBL] [Abstract][Full Text] [Related]
40. SESN2 correlates with advantageous prognosis in hepatocellular carcinoma. Chen S; Yan W; Lang W; Yu J; Xu L; Xu X; Liu Y; Bao H Diagn Pathol; 2017 Jan; 12(1):13. PubMed ID: 28118855 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]